Cofactoring and Dimerization of Proteinase-Activated Receptors

Proteinase-activated receptors (PARs) are G protein–coupled receptors that transmit cellular responses to extracellular proteases and have important functions in vascular physiology, development, inflammation, and cancer progression. The established paradigm for PAR activation involves proteolytic cleavage of the extracellular N terminus, which reveals a new N terminus that functions as a tethered ligand by binding intramolecularly to the receptor to trigger transmembrane signaling. Most cells express more than one PAR, which can influence the mode of PAR activation and signaling. Clear examples include murine PAR3 cofactoring of PAR4 and transactivation of PAR2 by PAR1. Thrombin binds to and cleaves murine PAR3, which facilitates PAR4 cleavage and activation. This process is essential for thrombin signaling and platelet activation, since murine PAR3 cannot signal alone. Although PAR1 and PAR4 are both competent to signal, PAR1 is able to act as a cofactor for PAR4, facilitating more rapid cleavage and activation by thrombin. PAR1 can also facilitate PAR2 activation through a different mechanism. Cleavage of the PAR1 N terminus by thrombin generates a tethered ligand domain that can bind intermolecularly to PAR2 to activate signaling. Thus, PARs can regulate each other’s activity by localizing thrombin when in complex with PAR3 and PAR4 or by cleaved PAR1, providing its tethered ligand domain for PAR2 activation. The ability of PARs to cofactor or transactivate other PARs would necessitate that the two receptors be in close proximity, likely in the form of a heterodimer. Here, we discuss the cofactoring and dimerization of PARs and the functional consequences on signaling.

[1]  J. Trejo,et al.  Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits β-Arrestin-mediated Endosomal Signaling* , 2013, The Journal of Biological Chemistry.

[2]  D. Kirchhofer,et al.  PAR-1 contributes to the innate immune response during viral infection. , 2013, The Journal of clinical investigation.

[3]  A. Arachiche,et al.  Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets , 2013, PloS one.

[4]  Jianyun Huang,et al.  Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.

[5]  J. Griffin,et al.  Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. , 2012, Blood.

[6]  R. Gainetdinov,et al.  BRET biosensors to study GPCR biology, pharmacology, and signal transduction , 2012, Front. Endocrin..

[7]  C. Pagel,et al.  Evaluation of antibodies directed against human protease-activated receptor-2 , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  S. Nuber,et al.  Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling , 2012, Pharmacological Reviews.

[9]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[10]  S. Mundell,et al.  Novel Role for Proteinase-activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR4)* , 2012, The Journal of Biological Chemistry.

[11]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[12]  M. Nieman,et al.  Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4* , 2012, The Journal of Biological Chemistry.

[13]  C. Esmon,et al.  Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. , 2012, Blood.

[14]  M. Hollenberg,et al.  Targeting proteinase-activated receptors: therapeutic potential and challenges , 2012, Nature Reviews Drug Discovery.

[15]  J. Trejo,et al.  Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds , 2011, Proceedings of the National Academy of Sciences.

[16]  A. Kuliopulos,et al.  Matrix metalloproteases and PAR1 activation. , 2011, Blood.

[17]  Michael R Dores,et al.  Adaptor Protein Complex-2 (AP-2) and Epsin-1 Mediate Protease-activated Receptor-1 Internalization via Phosphorylation- and Ubiquitination-dependent Sorting Signals* , 2011, The Journal of Biological Chemistry.

[18]  A. Bohm,et al.  Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins , 2011, Proceedings of the National Academy of Sciences.

[19]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[20]  S. Sligar,et al.  Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding* , 2010, The Journal of Biological Chemistry.

[21]  J. Javitch,et al.  Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. , 2010, Nature chemical biology.

[22]  Michael R Dores,et al.  Signal transduction by protease‐activated receptors , 2010, British journal of pharmacology.

[23]  C. Craik,et al.  Local protease signaling contributes to neural tube closure in the mouse embryo. , 2010, Developmental cell.

[24]  J. Trejo,et al.  Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization* , 2009, The Journal of Biological Chemistry.

[25]  N. Lambert,et al.  Instability of a Class A G Protein-Coupled Receptor Oligomer Interface , 2009, Molecular Pharmacology.

[26]  J. Trejo,et al.  Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.

[27]  Stefan Engelhardt,et al.  Analysis of receptor oligomerization by FRAP microscopy , 2009, Nature Methods.

[28]  S. Marullo,et al.  An escort for GPCRs: implications for regulation of receptor density at the cell surface. , 2008, Trends in pharmacological sciences.

[29]  N. Tinel,et al.  Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization , 2008, Nature Methods.

[30]  J. Bockaert,et al.  Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer. , 2008, Biophysical journal.

[31]  C. Derian,et al.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage , 2007, Nature Immunology.

[32]  A. Malik,et al.  Dual Regulation of Endothelial Junctional Permeability , 2007, Science's STKE.

[33]  E. Di Cera,et al.  Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4 , 2007, Proceedings of the National Academy of Sciences.

[34]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[35]  J. Griffin,et al.  The cytoprotective protein C pathway. , 2007 .

[36]  A. Malik,et al.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.

[37]  J. Trejo,et al.  Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer , 2007, Journal of Cell Science.

[38]  W. Thomas,et al.  Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. , 2006, Cellular signalling.

[39]  H. Hamm,et al.  PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation* , 2006, Journal of Biological Chemistry.

[40]  D. Siderovski,et al.  Clathrin Adaptor AP2 Regulates Thrombin Receptor Constitutive Internalization and Endothelial Cell Resensitization , 2006, Molecular and Cellular Biology.

[41]  C. Derian,et al.  Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis , 2006, Circulation.

[42]  F. Hamdan,et al.  Monitoring Protein‐Protein Interactions in Living Cells by Bioluminescence Resonance Energy Transfer (BRET) , 2006, Current protocols in neuroscience.

[43]  A. Samarel,et al.  A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells. , 2005, American journal of physiology. Cell physiology.

[44]  C. Feistritzer,et al.  Protease‐activated receptors‐1 and ‐2 can mediate endothelial barrier protection: role in factor Xa signaling , 2005, Journal of thrombosis and haemostasis : JTH.

[45]  S. Coughlin,et al.  Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.

[46]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[47]  J. Trejo,et al.  Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.

[48]  Michel Bouvier,et al.  Real-time monitoring of ubiquitination in living cells by BRET , 2004, Nature Methods.

[49]  Jean-François Mercier,et al.  Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.

[50]  L. Brass,et al.  Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. , 2004, Molecular cancer research : MCR.

[51]  J. Trejo,et al.  Termination of Protease-activated Receptor-1 Signaling by β-Arrestins Is Independent of Receptor Phosphorylation* , 2004, Journal of Biological Chemistry.

[52]  K. Fuxe,et al.  Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.

[53]  S. Schulz,et al.  Heterodimerization of Substance P and μ-Opioid Receptors Regulates Receptor Trafficking and Resensitization* , 2003, Journal of Biological Chemistry.

[54]  A. Kuliopulos,et al.  Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. , 2003, The Biochemical journal.

[55]  Francesca Fanelli,et al.  Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization , 2003, Journal of Biological Chemistry.

[56]  J. Baleja,et al.  Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. , 2003, Chemistry & biology.

[57]  M. Simon,et al.  G13 is an essential mediator of platelet activation in hemostasis and thrombosis , 2003, Nature Medicine.

[58]  L. Prézeau,et al.  Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.

[59]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[60]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[61]  Wei Huang,et al.  Role of thrombin signalling in platelets in haemostasis and thrombosis , 2001, Nature.

[62]  S. Coughlin,et al.  A Role for Thrombin Receptor Signaling in Endothelial Cells During Embryonic Development , 2001, Science.

[63]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[64]  L. Brass,et al.  Protease activated receptors: theme and variations , 2001, Oncogene.

[65]  M. LeMasurier,et al.  Substrate-Assisted Catalysis of the PAR1 Thrombin Receptor , 2000, The Journal of Biological Chemistry.

[66]  S. Coughlin,et al.  Protease-activated Receptors 1 and 4 Are Shut Off with Distinct Kinetics after Activation by Thrombin* , 2000, The Journal of Biological Chemistry.

[67]  N. Prévost,et al.  Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.

[68]  A. Kuliopulos,et al.  Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. , 2000, Biochemistry.

[69]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[70]  R. Mullins,et al.  β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.

[71]  S. Coughlin,et al.  How the protease thrombin talks to cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Coughlin,et al.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. , 1999, The Journal of clinical investigation.

[73]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[74]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[75]  S. Coughlin,et al.  Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.

[76]  J. Hoxie,et al.  Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.

[77]  S. Coughlin,et al.  Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking , 1996, The Journal of Biological Chemistry.

[78]  R. Scarborough,et al.  Ligand Cross-reactivity within the Protease-activated Receptor Family* , 1996, The Journal of Biological Chemistry.

[79]  J. Pouysségur,et al.  Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (*) , 1995, The Journal of Biological Chemistry.

[80]  S. Coughlin Protease-activated receptors start a family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[81]  C. Wahlestedt,et al.  Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Chen,et al.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. , 1994, The Journal of biological chemistry.

[83]  Paul R. Selvin,et al.  Luminescence resonance energy transfer , 1994 .

[84]  P. Dennington,et al.  THE THROMBIN RECEPTOR , 1994, Clinical and experimental pharmacology & physiology.

[85]  V. Wheaton,et al.  Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. , 1992, The Journal of biological chemistry.

[86]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[87]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[88]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[89]  Jason M. Conley,et al.  Bimolecular fluorescence complementation analysis of G protein-coupled receptor dimerization in living cells. , 2013, Methods in enzymology.

[90]  R. Stevens,et al.  Structure of the human k-opioid receptor in complex with JDTic , 2012 .

[91]  L. Devi,et al.  Exploring a role for heteromerization in GPCR signalling specificity. , 2011, The Biochemical journal.

[92]  H. Hamm,et al.  Heterotrimeric G protein activation by G-protein-coupled receptors , 2008, Nature Reviews Molecular Cell Biology.

[93]  R. Buser,et al.  Calcium mobilization. , 2000, Methods in molecular biology.

[94]  N. Prévost,et al.  Thrombin Responses in Human Endothelial Cells CONTRIBUTIONS FROM RECEPTORS OTHER THAN PAR1 INCLUDE THE TRANSACTIVATION OF PAR2 BY THROMBIN-CLEAVED PAR1* , 2000 .

[95]  S. Coughlin,et al.  Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. , 1998, Blood.

[96]  M. Simon,et al.  Defective platelet activation in G alpha(q)-deficient mice. , 1997, Nature.

[97]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.